A customer walks in asking for a small-breed senior formula with joint support. Five years ago, you pointed them to Hill's or Royal Canin. Today, a 100-store chain in the UK is pointing them to its own house brand.
Optimum Pet Health does not read like private label
Jollyes, a UK pet retail chain with over 100 locations, just launched Optimum Pet Health (OPH), a house-brand nutrition range that doesn't look like traditional private label. The line features breed-size segmentation (small, medium, large), life-stage formulas, and functional claims like weight control. Both wet and dry formats. The positioning language, 'OptiThrive blend of selected nutrients, vitamins and minerals', reads like a national brand's back panel, not a discount fill-in.
This isn't a value tier play. It's a direct move into the premium shelf space independents thought chains would leave alone.
The premium tier stopped belonging to national brands
For the last decade, the private label nutrition story in pet was pretty consistent: chains owned the budget tier, national brands owned the premium tier, and independents competed on curation and trust in the middle and top. A house brand meant 'good enough for price-sensitive customers,' not 'competes with Science Diet on functional claims.'
Jollyes just broke that script. Breed-specific SKUs and targeted health benefits require real formulation work, regulatory clearance in some markets, and supply chain complexity. That's the kind of investment you make when you're building margin AND traffic, not just margin. When a chain can afford to launch eight or ten SKUs with that level of segmentation, it's no longer ceding the navigation advantage to the brands you stock. It's building its own.
The implication: Private label is no longer just the cheap option at checkout. It's becoming the house expert. And if a 100-store regional chain can pull this off, the big-box operators watching this launch are taking notes.
Your nutrition margin got more vulnerable
For the store owner: Your nutrition margin just became more vulnerable. The category where independents historically held an edge, trust, expertise, premium assortment, now has a competitor that doesn't pay slotting fees and doesn't need your shelf. If a customer can get breed-specific formulas and functional claims from a chain's house brand at a better price, your pitch has to shift from 'we carry the good stuff' to 'here's why THIS brand is worth the premium.' That's a harder conversation, and it happens at every transaction.
For the buyer: If a 100-store chain can afford breed-size segmentation and functional positioning, your assortment strategy needs a margin vs. trust audit now. Ask: which SKUs in my nutrition set are vulnerable to a house-brand equivalent? Where does the national brand actually deliver something a private label can't copy in 18 months? And where are you stocking six SKUs that do the same job because a rep asked nicely? The chains are tightening their assortments around house brands that do more work per facing. You should too.
For the brand/DTC operator: Specialty retail's private label sophistication just jumped. Your pitch to independents can't rely on them needing you for credibility anymore. If Jollyes can build functional claims into a house brand, the buyer you're calling on is asking: what does your brand do that their private label guy can't? The answer has to be innovation velocity, clinical backing, or a customer segment the house brand won't chase. 'We're premium' isn't enough.
Private label is no longer just the cheap option at checkout. It's becoming the house expert.